Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...
The incidence of poliomyelitis, once a dreaded and disabling illness, is extremely rare these days, although worrisome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback